Fluorine in PDB 3ozl: Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid.
Protein crystallography data
The structure of Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid., PDB code: 3ozl
was solved by
L.M.T.R.Lima,
L.C.Palmieri,
D.Foguel,
F.L.Palhano,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
26.14 /
1.90
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
43.930,
85.607,
65.228,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
19.9 /
24.7
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid.
(pdb code 3ozl). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid., PDB code: 3ozl:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 3ozl
Go back to
Fluorine Binding Sites List in 3ozl
Fluorine binding site 1 out
of 6 in the Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid.
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:43.1
occ:0.50
|
F1
|
A:FLF501
|
0.0
|
43.1
|
0.5
|
C7'
|
A:FLF501
|
1.3
|
42.8
|
0.5
|
F3
|
A:FLF501
|
2.1
|
43.2
|
0.5
|
F2
|
A:FLF501
|
2.1
|
41.9
|
0.5
|
C3'
|
A:FLF501
|
2.3
|
42.5
|
0.5
|
C4'
|
A:FLF501
|
3.2
|
42.7
|
0.5
|
C2'
|
A:FLF501
|
3.3
|
42.8
|
0.5
|
CD2
|
A:LEU110
|
3.5
|
16.7
|
1.0
|
C5'
|
A:FLF501
|
4.4
|
42.3
|
0.5
|
CG
|
A:LEU110
|
4.6
|
16.0
|
1.0
|
CD1
|
A:LEU110
|
4.6
|
15.8
|
1.0
|
C1'
|
A:FLF501
|
4.7
|
43.0
|
0.5
|
O
|
A:HOH206
|
4.8
|
37.3
|
0.5
|
|
Fluorine binding site 2 out
of 6 in 3ozl
Go back to
Fluorine Binding Sites List in 3ozl
Fluorine binding site 2 out
of 6 in the Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid.
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:41.9
occ:0.50
|
F2
|
A:FLF501
|
0.0
|
41.9
|
0.5
|
C7'
|
A:FLF501
|
1.3
|
42.8
|
0.5
|
F3
|
A:FLF501
|
2.1
|
43.2
|
0.5
|
F1
|
A:FLF501
|
2.1
|
43.1
|
0.5
|
C3'
|
A:FLF501
|
2.3
|
42.5
|
0.5
|
C2'
|
A:FLF501
|
2.9
|
42.8
|
0.5
|
C4'
|
A:FLF501
|
3.5
|
42.7
|
0.5
|
C1'
|
A:FLF501
|
4.4
|
43.0
|
0.5
|
C5'
|
A:FLF501
|
4.7
|
42.3
|
0.5
|
|
Fluorine binding site 3 out
of 6 in 3ozl
Go back to
Fluorine Binding Sites List in 3ozl
Fluorine binding site 3 out
of 6 in the Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid.
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:43.2
occ:0.50
|
F3
|
A:FLF501
|
0.0
|
43.2
|
0.5
|
C7'
|
A:FLF501
|
1.3
|
42.8
|
0.5
|
F2
|
A:FLF501
|
2.1
|
41.9
|
0.5
|
F1
|
A:FLF501
|
2.1
|
43.1
|
0.5
|
C3'
|
A:FLF501
|
2.4
|
42.5
|
0.5
|
C4'
|
A:FLF501
|
2.7
|
42.7
|
0.5
|
O
|
A:HOH206
|
3.2
|
37.3
|
0.5
|
C2'
|
A:FLF501
|
3.7
|
42.8
|
0.5
|
CD2
|
A:LEU110
|
4.0
|
16.7
|
1.0
|
C5'
|
A:FLF501
|
4.1
|
42.3
|
0.5
|
OG
|
A:SER117
|
4.9
|
19.6
|
0.5
|
C1'
|
A:FLF501
|
5.0
|
43.0
|
0.5
|
|
Fluorine binding site 4 out
of 6 in 3ozl
Go back to
Fluorine Binding Sites List in 3ozl
Fluorine binding site 4 out
of 6 in the Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid.
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F502
b:37.6
occ:0.50
|
F1
|
B:FLF502
|
0.0
|
37.6
|
0.5
|
C7'
|
B:FLF502
|
1.3
|
38.6
|
0.5
|
F2
|
B:FLF502
|
2.1
|
38.2
|
0.5
|
F3
|
B:FLF502
|
2.2
|
38.4
|
0.5
|
C3'
|
B:FLF502
|
2.3
|
38.8
|
0.5
|
C2'
|
B:FLF502
|
3.1
|
39.1
|
0.5
|
C4'
|
B:FLF502
|
3.2
|
38.8
|
0.5
|
CD2
|
B:LEU110
|
3.7
|
15.8
|
1.0
|
C1'
|
B:FLF502
|
4.4
|
39.0
|
0.5
|
C5'
|
B:FLF502
|
4.4
|
39.1
|
0.5
|
CG
|
B:LEU110
|
4.7
|
14.2
|
1.0
|
CD1
|
B:LEU110
|
4.8
|
14.7
|
1.0
|
O
|
B:HOH153
|
4.8
|
28.1
|
0.5
|
C6'
|
B:FLF502
|
4.9
|
39.0
|
0.5
|
|
Fluorine binding site 5 out
of 6 in 3ozl
Go back to
Fluorine Binding Sites List in 3ozl
Fluorine binding site 5 out
of 6 in the Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid.
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F502
b:38.2
occ:0.50
|
F2
|
B:FLF502
|
0.0
|
38.2
|
0.5
|
C7'
|
B:FLF502
|
1.3
|
38.6
|
0.5
|
F1
|
B:FLF502
|
2.1
|
37.6
|
0.5
|
F3
|
B:FLF502
|
2.2
|
38.4
|
0.5
|
C3'
|
B:FLF502
|
2.3
|
38.8
|
0.5
|
C2'
|
B:FLF502
|
2.7
|
39.1
|
0.5
|
C4'
|
B:FLF502
|
3.6
|
38.8
|
0.5
|
C1'
|
B:FLF502
|
4.1
|
39.0
|
0.5
|
C5'
|
B:FLF502
|
4.7
|
39.1
|
0.5
|
C6'
|
B:FLF502
|
4.9
|
39.0
|
0.5
|
N
|
B:FLF502
|
4.9
|
38.8
|
0.5
|
|
Fluorine binding site 6 out
of 6 in 3ozl
Go back to
Fluorine Binding Sites List in 3ozl
Fluorine binding site 6 out
of 6 in the Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid.
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F502
b:38.4
occ:0.50
|
F3
|
B:FLF502
|
0.0
|
38.4
|
0.5
|
C7'
|
B:FLF502
|
1.3
|
38.6
|
0.5
|
F1
|
B:FLF502
|
2.2
|
37.6
|
0.5
|
F2
|
B:FLF502
|
2.2
|
38.2
|
0.5
|
C3'
|
B:FLF502
|
2.3
|
38.8
|
0.5
|
C4'
|
B:FLF502
|
2.7
|
38.8
|
0.5
|
O
|
B:HOH153
|
3.2
|
28.1
|
0.5
|
C2'
|
B:FLF502
|
3.6
|
39.1
|
0.5
|
C5'
|
B:FLF502
|
4.1
|
39.1
|
0.5
|
CD2
|
B:LEU110
|
4.1
|
15.8
|
1.0
|
C1'
|
B:FLF502
|
4.7
|
39.0
|
0.5
|
OG
|
B:SER117
|
4.8
|
18.6
|
0.5
|
C6'
|
B:FLF502
|
4.9
|
39.0
|
0.5
|
|
Reference:
L.M.T.R.Lima,
L.C.Palmieri,
D.Foguel,
F.L.Palhano.
Crystal Structure of Human Transthyretin Variant A25T in Complex with Flufenamic Acid. To Be Published.
Page generated: Wed Jul 31 21:34:57 2024
|